Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.
https://healthspies.com/news/topical-jak-inhibitor-shows-promise-in-vitiligo/
Leg, RNS 1st thing would be great, but personally think their last RNS included info they want to share with possible licencing partners, but who knows with Sareum, fingers crossed were nearly .
with you there Gun, slow and steady upward till news lands
GLALTH's
From last Fridays RNS
The Company will hold a presentation to investors on 28 April 2021 at 11.00 a.m. via the Investor Meet Company platform. The presentation is open to all existing and potential shareholders. Questions can be submitted before the event via the Investor Meet Company dashboard up until 9:00 a.m. the day before the meeting or at any time during the live presentation. Please click on this link to register to attend:
https://www.investormeetcompany.com/sareum-holdings-plc/register-investor
https://www.investormeetcompany.com/sareum-holdings-plc/register-investor
https://www.nature.com/articles/d41573-021-00068-w
interesting read...
Is he related to Tim, or have i been watching to many of his presentations??
UKRI connected to Oxford...
GLALTH's, itchy palms be kicking in soon..;)
https://www.recoverytrial.net/
https://www.google.co.uk/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwiY2_fs3ZzwAhVhu3EKHaNJDDYQFjAGegQICxAD&url=https%3A%2F%2Facademic.oup.com%2Frheumatology%2Fadvance-article-pdf%2Fdoi%2F10.1093%2Frheumatology%2Fkeab386%2F37351380%2Fkeab386.pdf&usg=AOvVaw0PhVF-5w4oD7aDvI8Rz8Ki
and then comes along our 1801 to pull their pants down and show em how's its done ;)
from 8:30
https://pod.co/share-talk/share-talk-bulletin-board-heroes-monday-26th-april-2021
Good morning, i know where my money is... and its looking favourable for CTA
· Initial results are encouraging and demonstrate that SDC-1801 reduces the levels of cytokines associated with Acute Respiratory Distress Syndrome in human lung cells infected with SARS-CoV-2
· Exploratory Clinical Trial Application ("CTA") expected to be filed mid-year 2021 subject to successful completion of final toxicity and safety studies
Its all becoming very real as well as scary for Sareum holders, lets hope the Sareum team can keep up to speed with the huge workload that could land on their laps overnight.
Thiers molecules are finally being recognised, we haven't long to wait for the rerate, imagine 1801 being a one horse race.. Am loaded and ready to go
GLALTH's
Lets not forget, its The UK's "new" Antivirals Taskforce
Parker's tweet spells it out for me... Sareum are in with the taskforce already!!
Think the demand for fuel is due, Sareum definitely primed to rocket;)
Fingers crossed All
https://www.taconic.com/taconic-insights/microbiome-and-germ-free/microbial-inosine-enhances-immune-checkpont-response.html
so calling to our experts;), does this mean in layman's terms that bacterial metabolites assist checkpoint inhibitors in cancer?..
Lets not forget , from the PM
They are committed to finding 'novel antiviral medicines', the Department of Health said, meaning drugs not currently being used by the NHS are being rushed through clinical trials over the summer.
https://www.msn.com/en-gb/health/medical/britain-will-have-pills-to-treat-covid-at-home-by-the-autumn/ar-BB1fRm81?ocid=entnewsntp
"drugs not currently being used by the NHS are being rushed through clinical trials over the summer."
Its a no brainer UKRI must be communicating with the government..
GLALTH's
The Agile trials are happening, no time for a Dilly dally, don't want 1801 left in the storeroom like 737!
https://news.liverpool.ac.uk/2021/04/20/first-patient-dosed-in-latest-stage-of-agile-covid-19-drug-trial/
seems a bit surreal.. Absolute massive covid 19 treatment potential, we have a possible blockbuster, radio silence, no news is good news. Think we would have heard if no good by now?
GLALTH's, preclinical days are nearly up...